Lucid Diagnostics Inc. (LUCD) stock
LUCDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/3034% above fair value
$0.40−0.05 (-11.42%)
Close on Nov 16, 2026Market cap $80.85MP/E –Yield –
Lucid Diagnostics r&d expenses
Research and development expenses are spending on new products and technology.
Lucid Diagnostics's R&D Expenses for the twelve months ending Jun 30, 2026 was $5.39M, down 7.0% year over year. For fiscal 2025 it was $5.68M, down 5.2% from the year before. The highest annual figure on record is $11.26M in fiscal 2022.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.68M | -5.2% |
| FY2024 | Dec 31, 2024 | $5.99M | -17.4% |
| FY2023 | Dec 31, 2023 | $7.25M | -35.6% |
| FY2022 | Dec 31, 2022 | $11.26M | +21.1% |
| FY2021 | Dec 31, 2021 | $9.30M | +70.8% |
| FY2020 | Dec 31, 2020 | $5.44M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.19M | -5.0% |
| Q1 FY2026 | Mar 31, 2026 | $1.21M | -15.5% |
| Q4 FY2025 | Dec 31, 2025 | $1.72M | +18.6% |
| Q3 FY2025 | Sep 30, 2025 | $1.27M | -23.6% |
| Q2 FY2025 | Jun 30, 2025 | $1.26M | -8.5% |
| Q1 FY2025 | Mar 31, 2025 | $1.43M | -4.9% |
| Q4 FY2024 | Dec 31, 2024 | $1.45M | -24.2% |
| Q3 FY2024 | Sep 30, 2024 | $1.67M | +3.2% |
| Q2 FY2024 | Jun 30, 2024 | $1.37M | -24.9% |
| Q1 FY2024 | Mar 31, 2024 | $1.50M | -20.7% |
| Q4 FY2023 | Dec 31, 2023 | $1.92M | -21.5% |
| Q3 FY2023 | Sep 30, 2023 | $1.62M | -40.3% |
| Q2 FY2023 | Jun 30, 2023 | $1.83M | -46.9% |
| Q1 FY2023 | Mar 31, 2023 | $1.89M | -34.3% |
| Q4 FY2022 | Dec 31, 2022 | $2.44M | -29.9% |
| Q3 FY2022 | Sep 30, 2022 | $2.70M | +23.5% |
| Q2 FY2022 | Jun 30, 2022 | $3.44M | +83.7% |
| Q1 FY2022 | Mar 31, 2022 | $2.88M | +64.4% |
| Q4 FY2021 | Dec 31, 2021 | $3.48M | +90.7% |
| Q3 FY2021 | Sep 30, 2021 | $2.19M | +80.1% |
| Q2 FY2021 | Jun 30, 2021 | $1.87M | – |
| Q1 FY2021 | Mar 31, 2021 | $1.75M | – |
| Q4 FY2020 | Dec 31, 2020 | $1.83M | – |
| Q3 FY2020 | Sep 30, 2020 | $1.22M | – |
See a number that looks wrong?